Review on obesity management: diet, exercise and pharmacotherapy
GLP-1 Analogues Market Snapshot Frequently Asked Questions How big was the global GLP-1 analogues market in 2024
As a class, the GLP-1RAs have all been shown to have a body weight-reducing effect without clinically significant differences in body weight reduction between short-acting and long-acting GLP-1RAs
They typically order medium to large bulk quantities and require full certificates of analysis for every batch
c) Kidney Protection By improving blood flow and reducing inflammation, GLP-1 drugs can delay diabetic kidney disease progression
The misuse of GLP-1 drugs without clinical oversight can lead to severe health complications. GLP-1 receptor agonist drugs carry serious side effects ranging from nausea and vomiting to pancreatitis, acute kidney injury, bowel obstruction, and medullary thyroid cancer, the Ministry of Health and Family Welfare warned on 1 April, 2026